FindTrial
Sign In

A real world study for Benvitimod cream in the treatment of Palmoplantar pustulosis

A real world study for Benvitimod cream in the treatment of Palmoplantar pustulosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043862
Enrollment
Unknown
Registered
2021-03-04
Start date
2021-03-03
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

palmoplantar pustulosis

Interventions

Case series:palmar and plantar pustulosis

Sponsors

The First Center Hospital of Tianjin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Judging by the researchers, the application of cream in the treatment of palmar and plantar pustulosis; 2. is not pregnant and do not plan to pregnant women during the study; 3. fully aware of the research content, voluntarily participating in the study, has signed a consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy, breastfeeding women, or preparation of men / women during pregnancy; 2. known to be allergic to the research activity of drug components or accessories; 3. patients may not be able to complete the study for other reasons, or researchers think it is not appropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Palmoplantar Pustulosis Area and Severity Index (PPPASI);—

Secondary

MeasureTime frame
Dermatology Life Quality Index (DLQI);—

Countries

China

Contacts

Public ContactGuangping Wang

The First Center Hospital of Tianjin

wgp198873@163.com+86 18622199956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026